The Spanish Agency for Medicines and Medical Devices (AEMPS) has confirmed a total of 111 cases of breast implant-associated anaplastic large cell lymphoma (ALCL) up to 2025, a rare type of cancer linked to breast implants. In all, the agency has received 146 suspected reports since it began monitoring this condition in 2012.
The figures appear in the sixth follow-up report on the national protocol for the detection and study of this type of lymphoma, drawn up on the basis of notifications recorded in the Medical Devices Surveillance System. For years now, AEMPS has been carrying out specific monitoring of this disease together with medical societies and European health authorities.
